Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000912282-12-000009
Filing Date
2012-01-04
Accepted
2012-01-04 14:43:59
Documents
5
Period of Report
2012-01-04

Document Format Files

Seq Description Document Type Size
1 tekmira6k_01042012.htm 6-K 17213
2 MATERIAL CHANGE REPORT DATED JANUARY 3, 2011 ex99_1.htm EX-99.1 20773
3 tekmiramcr_p1.jpg GRAPHIC 152006
4 tekmiramcr_p2.jpg GRAPHIC 48936
5 tekmira_logo.jpg GRAPHIC 8366
  Complete submission text file 0000912282-12-000009.txt   327809
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34949 | Film No.: 12505537
SIC: 2834 Pharmaceutical Preparations